Skip to content
MarketScale
‹ Back to IndustriesSciences

Oscar Martin Interview – AMI Single Serve Tampa – 2026

The single-serve coffee industry is evolving as convenience and sustainability coexist in innovation. The focus is on commercial solutions like compostable and recyclable packaging. Industry experts like Oscar Martin and Daniel Dutesco from TekniPlex provide insights into the sustainable transformation of coffee capsules.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Tekniplex · Coffee Capsule InnovationCompostable Coffee PodsMaterial ScienceRecyclable Packaging
Share

Key takeaways

01

Convenience and sustainability are now parallel priorities in the coffee industry.

02

Material science is critical to maintaining taste and stability in sustainable packaging.

03

Anticipating unmet needs is essential for leading innovation in coffee capsules.

 
The single-serve coffee industry is at a pivotal moment, where convenience and sustainability are no longer competing priorities but parallel expectations shaping innovation. At gatherings like the AMI Single Serve Coffee Conference in Tampa, the conversation has clearly shifted from abstract goals to tangible, commercially viable solutions—especially in the realm of compostable and recyclable packaging. Yet, as new materials emerge, the industry faces a familiar but critical tension: how to maintain the premium taste and shelf-life stability consumers expect while transitioning to more sustainable formats. This challenge underscores a broader transformation, where material science is becoming just as central to the coffee experience as the beans themselves.

At the same time, evolving labeling standards, certification pathways, and performance requirements are adding layers of complexity that demand faster collaboration and smarter prototyping. Companies that can anticipate unmet needs and move beyond incremental improvements will define the next wave of innovation in this fast-moving market. To better understand how these dynamics are shaping the future of single-serve capsules, we turn to insights from Oscar Martin, Senior Vice President, and Daniel Dutesco, Global Marketing Director and Demand Generation at TekniPlex.

Video TranscriptExpand ↓

Hello, it's end of day one at the AMI Single Serve Coffee Conference in Tampa. Oscar, thank you again for agreeing to present. Pleasure. For coming to Tampa and making time for us. It is. It's end of day one. So, obviously, there was lots of different topics, lots of different conversations today. What trickled to the top for you? What were some of the things that you kept reoccurring in the conversation that you keep hearing over and over? Yeah. Great question, Daniel. There are some key themes around upholstability. Right? There are some new technology providers that are out there that have mere commercial ready solutions that we would like to have some follow-up conversations around. Yeah. Some some discussion around how to effectively and what are the requirements for labeling from a sustainability perspective. Yeah. You know, the shelf life requirements for compostable products, the certifications, where to get those certifications certified at. And so I think there's definitely some follow-up conversations we want to have with some of those technology think some of the challenges for them that came was, you know, what about taste? How does it compostable, does the experience also come through in the end product? So how does with your traditional cups? Absolutely. So second question, you presented today Yes. On the future of kind of how to future proof single serve capsules. Take me through a little bit through the presentation. Oh, We went through the four waves of of, the consumer experience. Okay. And that fourth wave is all about the next generation and how that experience is coming to life. And most importantly, how can Material Science Solutions enable that whole experience, you know, with regard to premium, taste and flavor through shelf life stability, affordability and convenience. Okay. If from all those different things, if there's one thing you would like people to take away from, the different conversations you had with them Oh, yeah. What would it be? It's a very dynamic market. Things are moving at a very fast scale, which is why responding to customer unmet needs is important. Rapid prototyping, proof of concepts, so we can be two steps ahead from a market perspective and not be a fast follower. Yeah. For me, it's, as well if I can, I think everything you put together at the GIC, hearing the people talk, it's again coming back to the offer we're building there is actually very, very exciting and promising? Absolutely. And and having multiple solutions that are ready Yeah. Whether it's molded fiber Yeah. Or whether it's paper, whether it's recyclable plastic solutions with PCR, you have to be ready with alternatives because this market is moving at a phenomenal pace. That's incredible. Alright. Thank you again. Thank you. Thank you. I look forward to the next next time I recruit you into to come to Zen. Alright. Thank you very much. Alright. Take care. Bye bye.

About the author

T
Tekniplex

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Sciences expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics has hired Neil Anderson, Ph.D. as the Chief Revenue Officer to spearhead the commercialization of its nanoimprint flat optics platform. The platform is intended for use in AI datacenters, augmented reality (AR), and life sciences applications. Anderson's experience in photonics is expected to aid Myrias Optics in expanding its market presence in these sectors.

  • 01Myrias Optics appointed Neil Anderson, Ph.D. as CRO to lead the commercialization of its technology.
  • 02The company focuses on nanoimprint flat optics for AI datacenters, AR, and life sciences.
  • 03Neil Anderson brings extensive photonics expertise to support Myrias Optics' growth.

Jul 31, 2026

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

T
Tekniplex
OM
Oscar Martin

Senior Vice President

TekniPlex

DD
Daniel Dutesco

Global Marketing Director and Demand Generation

TekniPlex

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512